Stefan Lebrun
Papers
1
Total Citations
52
H-Index
1
About
Dr. Stefan Lebrun is a biomedical researcher whose work centers on the intersection of environmental toxicology and cardiovascular disease, with a particular focus on how lifestyle factors disrupt lipid metabolism and promote atherosclerosis. His most-cited study, "Modulation of atherogenic lipidome by cigarette smoke in apolipoprotein E-deficient mice" (2012, 52 citations), represents a seminal contribution to understanding the mechanistic links between smoking and heart disease. In this work, Lebrun demonstrated that chronic exposure to cigarette smoke fundamentally alters the lipid profile—shifting it toward a more pro-atherogenic composition—in a widely used mouse model of atherosclerosis. By mapping specific lipidomic changes, his research provided critical evidence that smoking does not merely accelerate existing disease processes but actively reshapes the molecular landscape of lipid transport and inflammation. This finding has implications for both public health messaging and the development of targeted interventions for smokers at risk of cardiovascular events. Lebrun’s work is distinguished by its integration of sophisticated lipidomics with in vivo models, offering a clear, mechanistic view of how an environmental toxin drives pathological lipid remodeling. His contributions continue to inform studies on diet, pollution, and metabolic disease.
Research Focus
Key Achievements
Top Papers
- 1